William Hollifield, MD
Department of Psychiatry
University of Florida
Primary Care Physicians
This CME activity consists of an educational component (slides, audio lecture) in an electronic format, followed by an online post-test. Estimated time to complete this activity, including review of materials, is one hour.
Requirements for Successful Completion
As a result of participation in this activity, participants should be able to:
1.Define the pharmacological properties and the physiological effects of buprenorphine.
2.Describe the potential benefits and risks of buprenorphine.
3.Review the use of buprenorphine in managing opiate use disorder.
4.Assess the use of buprenorphine in both hospital and outpatient settings.
Dr. Hollifield has disclosed that he has no financial relationships to disclose. Dr. Bussing has disclosed that she has received research support from Pfizer. No one else in a position to control content has any financial relationships to disclose.
Continuing Medical Education Credit
Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.